Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Change in Acquisitions & Divestments (2017 - 2018)

Aptevo Therapeutics' Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $81.2 million for Q3 2018.

  • For Q3 2018, Change in Acquisitions & Divestments rose 237.73% year-over-year to $81.2 million; the TTM value through Sep 2018 reached $177.4 million, changed N/A, while the annual FY2018 figure was $90.2 million, 27.59% up from the prior year.
  • Change in Acquisitions & Divestments for Q3 2018 was $81.2 million at Aptevo Therapeutics, up from $52.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $81.2 million in Q3 2018 and bottomed at $8.1 million in Q1 2017.